Psychedelics Investing Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap's Mental Health Technology
Pharmaceutical Investing Independent Data Monitoring Committee Concludes OlympiA Trial of LYNPARZA® Crossed Superiority Boundary for Invasive Disease-Free Survival vs. Placebo at Planned Interim Analysis
Medical Device Investing Medtronic Announces Voluntary Recall of Unused Valiant Navion Thoracic Stent Graft System
Pharmaceutical Investing Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab in Multiple Myeloma
Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021
Pharmaceutical Investing Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
Life Science Investing BioHarvest Sciences CEO Ilan Sobel: Driving Human Utility Value Through Cannabis and SuperFruits
FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Medical Device Investing Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
Gilead Sciences and Wake Forest University School of Divinity Partner to Address HIV Epidemic Through Faith-Based Programming and Community Outreach
BioHarvest Sciences Inc. Announces Partnership with BOLDT and Summit Strategy Group to Develop a Sustainability Framework and ESG Report
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
